Journal of clinical anesthesia
-
Randomized Controlled Trial Multicenter Study
Parecoxib sodium administered over several days reduces pain after gynecologic surgery via laparotomy.
To assess the analgesic efficacy of a multidose, multiday regimen of intravenous (IV) parecoxib sodium (parecoxib). ⋯ Multidose parecoxib was well tolerated over several days and provided improved pain control after gynecologic surgery.
-
Multicenter Study
Patient perception of the role of anesthesiologists: a perspective from the Caribbean.
To assess patients' perception of the role of an anesthesiologist in a Caribbean country. ⋯ Patients still have inadequate knowledge regarding anesthesiologists and their different roles in hospitals.
-
Multicenter Study Comparative Study Clinical Trial
Comparison of direct and video-assisted views of the larynx during routine intubation.
To compare the direct and indirect (video monitor) views of the glottic opening using a new Macintosh blade that is modified to provide a video image of airway structures during laryngoscopy. ⋯ Video-assisted laryngoscopy provides an improved view of the larynx, as compared with direct visualization. This technique may be useful for cases of difficult intubation and reintubation as well as for teaching laryngoscopy and intubation.
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
Nasal versus oral fiberoptic intubation via a cuffed oropharyngeal airway (COPA) during spontaneous ventilation.
To compare the success rate of nasal versus oral fiberoptic intubation in anesthetized patients breathing spontaneously via the cuffed oropharyngeal airway (COPAtrade mark). ⋯ Nasal fiberoptic laryngoscopy is more successful and easy than the oral approach in anesthetized patients who are breathing spontaneously through the COPA.
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Timing of administration of dolasetron affects dose necessary to prevent postoperative nausea and vomiting.
To determine if the timing of administration affects the dose of dolasetron necessary to prevent postoperative nausea and vomiting (PONV). ⋯ When dosed near the end of anesthesia, a 12.5 mg IV dose of dolasetron was comparable to higher doses administered at or before induction of anesthesia.